As of 2:52pm ET
| -0.55 / -1.15%|
The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 45.50, with a high estimate of 54.00 and a low estimate of 36.00. The median estimate represents a -3.60% decrease from the last price of 47.20.
The current consensus among 4 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.